Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))
Clinical trial NCT01163292 · COMPLETED
Trial details
- NCT number
- NCT01163292
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.